3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
3
Polycystic Ovary Syndrome
2
Neoplasms
2
Urinary Bladder Neoplasms
1
Stage I Prostate Adenocarcinoma
1
Prostatic Neoplasms
1
Osteoporosis
1
Infertility
1
Endometrial Neoplasms
1
Diarrhea
1
Brain Neoplasms
1
Anovulation
1
Interventions
Clomiphene
18
Metformin
12
Letrozole
11
Triptorelin Pamoate
7
cetrorelix
5
Menotropins
5
Chorionic Gonadotropin
4
Surveys and Questionnaires
3
Sperm Injections, Intracytoplasmic
3
Medroxyprogesterone Acetate
3
Inositol
3
Gonadotropins
3
Folic Acid
3
Uterine Myomectomy
2
Tamoxifen
2
Sugars
2
Progestins
2
Liraglutide
2
High-Energy Shock Waves
2
Flutamide
2
ulipristal acetate
1
testosterone undecanoate
1
methyl N-acetylsibirosaminide
1
hMG-IBSA
1
follitropin alfa
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
Thyrotropin
1
Thioctic Acid
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Infertility
×
Raloxifene Hydrochloride
×
Clear all
NCT01607320
2018-09-20
PCOS
Prisma Health-Upstate
Phase NA
Terminated
3 enrolled
3 charts